Gyros PTi Webinar
Assessing the immunogenicity of biopharmaceuticals
Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing.
By attending this webinar, you will learn:
- how the Gyrolab™ platform automates drug-tolerant ADA immunoassays in a time-efficient way using small volumes of patient samples and reagents
- how iLite® Assay Ready reporter gene cell lines are designed to overcome limitations of conventional cell-based assays in the assessment of neutralizing antibodies
Cecilia Bill, Application Scientist, Gyros Protein Technologies AB
Frida Pauly, Manager Biopharma Solutions,Euro Diagnostica AB
Cecilia and Frida will answer your questions live during the broadcast!
Date: Thursday, November 9, 2017
Time: 10:00 AM Central European Time, (4:00 AM EST, 1:00 AM PST)
6:00 PM Central European Time, 12:00 PM EST, 9:00 AM PST
Contact Benjamin at firstname.lastname@example.org if you would like to participate.
Gyrolab is a trademark of Gyros Protein Technologies Group. iLite is a registered trademark of Euro Diagnostica.